LEPG Citations (4)

Originally described in: An optimized microRNA backbone for effective single-copy RNAi.
Fellmann C, Hoffmann T, Sridhar V, Hopfgartner B, Muhar M, Roth M, Lai DY, Barbosa IA, Kwon JS, Guan Y, Sinha N, Zuber J Cell Rep. 2013 Dec 26;5(6):1704-13. doi: 10.1016/j.celrep.2013.11.020. Epub 2013 Dec 12. PubMed Journal

---

Articles Citing LEPG

Articles
TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma. Somerville TDD, Xu Y, Miyabayashi K, Tiriac H, Cleary CR, Maia-Silva D, Milazzo JP, Tuveson DA, Vakoc CR. Cell Rep. 2018 Nov 13;25(7):1741-1755.e7. doi: 10.1016/j.celrep.2018.10.051. PubMed
EVI1 activates tumor-promoting transcriptional enhancers in pancreatic cancer. Kim HR, Yim J, Yoo HB, Lee SE, Oh S, Jung S, Hwang CI, Shin DM, Kim T, Yoo KH, Kim YS, Lee HW, Roe JS. NAR Cancer. 2021 Jun 17;3(2):zcab023. doi: 10.1093/narcan/zcab023. eCollection 2021 Jun. PubMed
Cytosolic galectin-4 enchains bacteria, restricts their motility, and promotes inflammasome activation in intestinal epithelial cells. Li CS, Lo TH, Tu TJ, Chueh DY, Yao CI, Lin CH, Chen P, Liu FT. Proc Natl Acad Sci U S A. 2023 Jan 31;120(5):e2207091120. doi: 10.1073/pnas.2207091120. Epub 2023 Jan 23. PubMed
A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer. Yoo HB, Moon JW, Kim HR, Lee HS, Miyabayashi K, Park CH, Ge S, Zhang A, Tae YK, Sub Y, Park HW, Gee HY, Notta F, Tuveson DA, Bang S, Kim MY, Roe JS. Gastroenterology. 2023 Jul;165(1):133-148.e17. doi: 10.1053/j.gastro.2023.02.049. Epub 2023 Mar 11. PubMed

If you have published an article using this material, please email us at to have your article added to this page.